ARK ETF TR - GENOMIC REV ETF (ARKG) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q4 2025

Type / Class: Equity / GENOMIC REV ETF
Symbol: ARKG
Price per share: $28.97
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 22,064,626
Total reported value: $613,071,397
% of total 13F portfolios: 0%
Share change: +676,314
Value change: +$21,472,538
Number of holders: 228

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, 228 institutional investors reported holding 22,064,626 shares of ARK ETF TR - GENOMIC REV ETF (ARKG).

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	596,345	$17,425,950	+$3,261,852			$28.97	39
2025 Q3	22,064,626	$613,071,397	+$21,472,538	$77,034,162	$64,265,200	$27.77	228
2025 Q2	21,611,541	$526,299,881	-$30,340,417	$106,621,580	$95,858,360	$24.35	208
2025 Q1	23,101,944	$479,673,052	-$55,581,611	$79,651,193	$96,541,347	$20.76	208
2024 Q4	24,359,584	$573,766,398	-$37,881,926	$58,275,400	$68,187,338	$23.54	233
2024 Q3	27,319,167	$699,250,691	+$92,150,396	$67,331,483	$75,124,351	$25.60	236
2024 Q2	22,697,563	$533,360,015	+$39,104,434	$153,622,596	$65,208,656	$23.48	255
2024 Q1	21,070,311	$605,869,850	+$29,425,107	$80,761,356	$42,222,556	$28.76	278
2023 Q4	18,854,497	$618,680,538	+$12,657,699	$68,018,411	$50,868,624	$32.81	295
2023 Q3	15,272,259	$424,908,985	-$83,636,429	$28,400,484	$28,213,822	$27.86	280
2023 Q2	19,519,789	$665,172,681	-$81,152,901	$22,095,139	$26,262,667	$34.09	285
2023 Q1	22,230,141	$668,316,409	+$77,890,388	$73,791,772	$26,010,924	$30.07	287
2022 Q4	18,500,202	$522,559,625	-$45,769,022	$32,145,995	$44,283,934	$28.23	308
2022 Q3	21,745,645	$714,574,611	+$11,094,001	$48,050,000	$67,928,000	$32.87	290
2022 Q2	19,759,934	$624,634,834	-$149,931,968	$51,496,000	$58,424,012	$31.49	311
2022 Q1	23,308,025	$1,070,074,056	+$44,471,414	$240,016,066	$177,620,066	$45.93	359
2021 Q4	22,717,723	$1,389,309,843	-$126,515,786	$443,388,000	$153,913,312	$61.24	440
2021 Q3	23,366,967	$1,745,726,599	-$180,784,054	$360,081,000	$194,655,000	$74.72	459
2021 Q2	25,659,492	$2,370,135,079	+$42,779,459	$809,267,000	$452,952,500	$92.50	505
2021 Q1	25,148,571	$2,232,467,554	+$479,464,342	$1,067,846,112	$460,764,900	$88.73	498
2020 Q4	19,547,660	$1,827,150,655	+$624,694,863	$405,561,000	$189,459,000	$93.26	406
2020 Q3	11,839,290	$755,235,763	+$171,057,097	$991,000	$2,235,000	$63.71	235
2020 Q2	9,170,973	$478,909,682	+$200,541,364			$52.16	162
2020 Q1	5,396,249	$168,815,107	+$40,925,746			$31.28	96
2019 Q4	4,132,689	$138,545,355	+$25,605,525			$33.52	89
2019 Q3	3,368,985	$99,496,769	+$11,087,055			$29.52	77
2019 Q2	2,944,601	$101,482,198	+$13,071,418			$34.47	66
2019 Q1	2,580,644	$84,862,049	+$18,849,778			$32.88	61
2018 Q4	2,072,523	$50,378,685	+$43,577			$23.98	56
2018 Q3	1,939,768	$64,843,220	+$26,818,878			$33.43	56
2018 Q2	1,154,665	$33,528,825	+$11,399,069			$29.06	46
2018 Q1	771,773	$19,868,520	+$11,638,695			$25.75	39
2017 Q4	319,927	$7,861,613	+$1,291,433			$24.49	18
2017 Q3	264,822	$6,957,723	+$2,355,604			$26.24	12
2017 Q2	174,830	$3,913,000	+$3,191,214			$22.38	8
2017 Q1	33,397	$689,000	-$16,347			$20.69	4
2016 Q4	34,527	$586,000	+$32,517			$17.01	5
2016 Q3	32,597	$648,000	-$411,759			$19.89	5
2016 Q2	53,282	$897,000	+$82,555			$16.79	4
2016 Q1	48,349	$848,000	+$343,311			$17.54	5
2015 Q4	28,783	$603,000	+$219,908			$20.95	3
2015 Q3	18,282	$343,000	-$327,901			$18.76	1
2015 Q2	35,623	$821,000	+$190,002			$23.05	3
2015 Q1	27,374	$623,000	-$292,145			$22.69	2
2014 Q4	40,223	$854,000	+$801,000			$21.22	2